¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - ¿ëµµº°(â»ó Ä¡À¯, ¿Ü°ú ¿ëµµ, ±âŸ ÀÇ·á ¿ëµµ), Áö¿ªº°, °æÀﺰ(2020-2030³â)
Cold Plasma in Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Wound Healing, Surgical Application and Other Medical Applications), By Region and Competition, 2020-2030F
¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀåÀº 2024³â¿¡ 21¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 42¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 12.11%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
ºñ¿Àû, ºñħ½ÀÀûÀÎ ÀÌ¿ÂÈ °¡½º ±â¼úÀÎ Äݵå ÇöóÁ´Â »óó Ä¡À¯, ¸ê±Õ, ¾Ï Ä¡·á, ÇǺΰú Ä¡·á µî Æø³ÐÀº ¿ëµµ·Î Çö´ëÀÇ ÇコÄɾ º¯ÇõÀ» °¡Á®¿À°í ÀÖ½À´Ï´Ù. °Ç°ÇÑ Á¶Á÷¿¡ ¼Õ»óÀ» ÁÖÁö ¾ÊÀ¸¸é¼ º´¿øÃ¼¸¦ ÆÄ±«Çϰí Á¶Á÷ Àç»ýÀ» ÃËÁøÇϸç Ç÷°ü½Å»ýÀ» ÀÚ±ØÇÏ´Â ±× ´É·ÂÀº ±ÍÁßÇÑ ÀÇ·á µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå °³¿ä |
¿¹Ãø ±â°£ |
2026-2030³â |
½ÃÀå ±Ô¸ð(2024³â) |
21¾ï 4,000¸¸ ´Þ·¯ |
½ÃÀå ±Ô¸ð(2030³â) |
42¾ï 5,000¸¸ ´Þ·¯ |
CAGR(2025-2030³â) |
12.11% |
±Þ¼ºÀå ºÎ¹® |
»óó Ä¡À¯ |
ÃÖ´ë ½ÃÀå |
ºÏ¹Ì |
ƯÈ÷ ´ç´¢º´À̳ª ¾Ï µî °íµµ·Î Àúħ½ÀÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÑ Áúȯ¿¡ ÀÖ¾î¼ ÇöÀúÇÕ´Ï´Ù. Äݵå ÇöóÁ´Â ¸¸¼º â»ó °ü¸® ¹× °¨¿° Á¦¾î Áö¿ø¿¡ ÀÖ¾î À¯¸ÁÇÑ °á°ú¸¦ ³ªÅ¸³»°í ÀÖÀ¸¸ç, ƯÈ÷ ÆÒµ¥¹Í ÈÄÀÇ ÇコÄɾî Àü·«¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °Ô´Ù°¡ °ø±âÁßÀÇ ¹ÙÀÌ·¯½º¸¦ °ÅÀÇ ¼ø°£¿¡ ºÒȰ¼ºÈÇÏ´Â Äݵå ÇöóÁÀÇ °¡´É¼ºÀÌ ÇмúÀû ¹× ÀÓ»óÀûÀ¸·Î Á¶»çµÇ¾î È£Èí ¿ä¹ý¿¡ ´ëÇÑ ¿ëµµ¿¡ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº, ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼, ½Å·Ú¼ºÀÌ ³ô°í Çõ½ÅÀûÀÎ Ä¡·á ¹× ¸ê±Õ ¼Ö·ç¼ÇÀ¸·Î¼ Äݵå ÇöóÁ ±â¼úÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀ» Áõ¸íÇϰí ÀÖ½À´Ï´Ù.
ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
¸¸¼º Áúȯ Áõ°¡
ÁÖ¿ä ½ÃÀå °úÁ¦
ÇコÄÉ¾î ¿öÅ©Ç÷ο쿡 ÅëÇÕ
ÁÖ¿ä ½ÃÀå µ¿Çâ
µ¥ÀÌÅÍ Áß½ÉÀÇ ÇコÄɾî
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå °í°´ÀÇ ¸ñ¼Ò¸®
Á¦5Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
- ¿ëµµº°(»óó Ä¡À¯, ¿Ü°ú ¿ëµµ, ±âŸ ÀÇ·á ¿ëµµ)
- Áö¿ªº°
- ±â¾÷º°(2024³â)
- ½ÃÀå ¸Ê
Á¦6Àå ºÏ¹ÌÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
- ºÏ¹Ì : ±¹°¡º° ºÐ¼®
Á¦7Àå À¯·´ÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
- À¯·´ : ±¹°¡º° ºÐ¼®
- µ¶ÀÏ
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ÇÁ¶û½º
- ½ºÆäÀÎ
Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º° ºÐ¼®
Á¦9Àå ³²¹ÌÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
- ³²¹Ì : ±¹°¡º° ºÐ¼®
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ÄÝ·Òºñ¾Æ
Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀå Àü¸Á
- ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
- ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ºÐ¼®
- ³²¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
Á¦11Àå ½ÃÀå ¿ªÇÐ
Á¦12Àå ½ÃÀå µ¿Çâ ¹× ¹ßÀü
Á¦13Àå ¼¼°èÀÇ ÇコÄÉ¾î ºÐ¾ß Àú¿Â ÇöóÁ ½ÃÀå :SWOT ºÐ¼®
Á¦14Àå Porter's Five Forces ºÐ¼®
- ¾÷°è ³» °æÀï
- ½Å±Ô ÁøÀÔÀÇ °¡´É¼º
- °ø±ÞÀÚÀÇ Èû
- °í°´ÀÇ Èû
- ´ëü Ä¡·á¹ýÀÇ À§Çù
Á¦15Àå °æÀï ±¸µµ
- Neoplas med GmbH
- US Medical Innovations
- Terumo Medical Corp
- Adtec Plasma Technology Co Ltd
- Apyx Medical Corp
- Nordson Corp
- Europlasma NV
- Terraplasma GmbH
- Henniker Plasma
- Smith & Nephew plc
Á¦16Àå Àü·«Àû Á¦¾È
Á¦17Àå ±â¾÷ ¼Ò°³ ¹× ¸éÃ¥»çÇ×
AJY
The Global Cold Plasma in Healthcare Market was valued at USD 2.14 Billion in 2024 and is projected to reach USD 4.25 Billion by 2030, growing at a CAGR of 12.11% during the forecast period. Cold plasma, a non-thermal, non-invasive ionized gas technology, is transforming modern healthcare with its wide range of applications, including wound healing, sterilization, cancer therapy, and dermatological treatments. Its ability to destroy pathogens, promote tissue regeneration, and stimulate angiogenesis without damaging healthy tissue makes it a valuable medical tool.
Market Overview |
Forecast Period | 2026-2030 |
Market Size 2024 | USD 2.14 Billion |
Market Size 2030 | USD 4.25 Billion |
CAGR 2025-2030 | 12.11% |
Fastest Growing Segment | Wound Healing |
Largest Market | North America |
The market is gaining momentum as chronic disease prevalence rises globally, particularly in conditions like diabetes and cancer that require advanced, minimally invasive treatments. Cold plasma is showing promising results in managing chronic wounds and aiding infection control-especially crucial in post-pandemic healthcare strategies. Additionally, with academic and clinical research highlighting cold plasma's potential to inactivate airborne viruses almost instantly, interest has surged for respiratory therapy applications. These developments underscore the increasing adoption of cold plasma technology as a reliable, innovative therapeutic and sterilization solution across diverse medical settings.
Key Market Drivers
Increasing Chronic Diseases
The growing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a major factor driving demand for cold plasma technologies in healthcare. According to the World Health Organization, noncommunicable diseases (NCDs) accounted for over 43 million deaths in 2021, with a disproportionate impact in low- and middle-income countries.
Cold plasma has emerged as a promising treatment modality for addressing the complications arising from these conditions. For instance, in diabetic patients, chronic ulcers present a persistent challenge; cold plasma accelerates healing by enhancing tissue oxygenation and reducing microbial load. Similarly, its application in oncology helps target cancer cells while sparing healthy tissue, offering an advanced alternative to traditional therapies. As healthcare systems globally aim to manage rising NCDs with precision and minimal side effects, the role of cold plasma technologies is becoming increasingly significant.
Key Market Challenges
Integration into Healthcare Workflows
One of the critical challenges in the cold plasma healthcare market is integrating these advanced technologies into established clinical workflows. Many healthcare facilities operate within strict procedural frameworks and require seamless compatibility with existing medical infrastructure.
Adopting cold plasma devices involves not only purchasing equipment but also modifying infrastructure, allocating physical space, and ensuring adequate training for clinical staff. These adjustments may be resource-intensive and time-consuming, particularly in smaller hospitals or facilities in developing regions. Without smooth integration, the potential clinical benefits of cold plasma may be underutilized or delayed, hampering market expansion despite the technology's efficacy.
Key Market Trends
Data-Driven Healthcare
The shift toward data-driven healthcare is reshaping how cold plasma devices are utilized. The integration of smart sensors and real-time monitoring capabilities allows healthcare providers to collect treatment data-such as gas flow, temperature, and dosage metrics-during procedures.
These insights enhance treatment precision and improve outcomes. For instance, in wound care, real-time feedback helps clinicians adjust parameters on-the-fly to accelerate healing. In oncology, data analytics can optimize dosage delivery to ensure cancer cells are effectively targeted. The ability to personalize treatment protocols based on real-time patient data marks a critical step in aligning cold plasma technology with the broader movement toward precision medicine and connected healthcare systems.
Key Market Players
- Neoplas med GmbH
- U.S. Medical Innovations
- Terumo Medical Corp
- Adtec Plasma Technology Co Ltd
- Apyx Medical Corp
- Nordson Corp
- Europlasma NV
- Terraplasma GmbH
- Henniker Plasma
- Smith & Nephew plc
Report Scope:
In this report, the Cold Plasma in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cold Plasma in Healthcare Market, By Application:
- Wound Healing
- Surgical Application
- Other Medical Applications
Cold Plasma in Healthcare Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Cold Plasma in Healthcare Market.
Available Customizations:
Cold Plasma in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validations
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cold Plasma in Healthcare Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Application (Wound Healing, Surgical Application and Other Medical Applications)
- 5.2.2. By Region
- 5.2.3. By Company (2024)
- 5.3. Market Map
6. North America Cold Plasma in Healthcare Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Cold Plasma in Healthcare Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Application
- 6.3.2. Canada Cold Plasma in Healthcare Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Application
- 6.3.3. Mexico Cold Plasma in Healthcare Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Application
7. Europe Cold Plasma in Healthcare Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Cold Plasma in Healthcare Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Application
- 7.3.2. United Kingdom Cold Plasma in Healthcare Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Application
- 7.3.3. Italy Cold Plasma in Healthcare Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecasty
- 7.3.3.2.1. By Application
- 7.3.4. France Cold Plasma in Healthcare Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Application
- 7.3.5. Spain Cold Plasma in Healthcare Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Application
8. Asia-Pacific Cold Plasma in Healthcare Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Cold Plasma in Healthcare Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Application
- 8.3.2. India Cold Plasma in Healthcare Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Application
- 8.3.3. Japan Cold Plasma in Healthcare Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Application
- 8.3.4. South Korea Cold Plasma in Healthcare Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Application
- 8.3.5. Australia Cold Plasma in Healthcare Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Application
9. South America Cold Plasma in Healthcare Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Cold Plasma in Healthcare Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Application
- 9.3.2. Argentina Cold Plasma in Healthcare Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Application
- 9.3.3. Colombia Cold Plasma in Healthcare Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Application
10. Middle East and Africa Cold Plasma in Healthcare Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Cold Plasma in Healthcare Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Application
- 10.3.2. Saudi Arabia Cold Plasma in Healthcare Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Application
- 10.3.3. UAE Cold Plasma in Healthcare Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Application
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Development
- 12.2. Mergers & Acquisitions
13. Global Cold Plasma in Healthcare Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Treatment Types
15. Competitive Landscape
- 15.1. Neoplas med GmbH
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Product & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
- 15.2. U.S. Medical Innovations
- 15.3. Terumo Medical Corp
- 15.4. Adtec Plasma Technology Co Ltd
- 15.5. Apyx Medical Corp
- 15.6. Nordson Corp
- 15.7. Europlasma NV
- 15.8. Terraplasma GmbH
- 15.9. Henniker Plasma
- 15.10. Smith & Nephew plc
16. Strategic Recommendations
17. About Us & Disclaimer